MAPT and major depressive disorder: The CSF levels of amyloid-β42 in the MDD group at baseline were significantly lower than those of the comparison group, whereas differences in CSF levels of amyloid-β40, and total and phosphorylated tau protein at baseline did not reach statistical significance across conditions (Table 1).26